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Long underappreciated as important cellular organelles, lipid droplets are finally being recognized 
as dynamic structures with a complex and interesting biology. In light of this newfound respect, we 
discuss emerging views on lipid droplet biology and speculate on the major advances to come.Long perceived as inert fat particles, 
lipid droplets (LDs) have been largely 
ignored by cell biologists. However, 
more recently, LDs are increasingly rec-
ognized as dynamic organelles that rep-
resent a frontier for cell biology.
These ubiquitous organelles are found 
in most eukaryotic cells (Figure 1; see 
SnapShot, this issue). They range greatly 
in size (diameter < 1–100 µm), and each 
consists of a phospholipid monolayer 
that surrounds a core of neutral lipids, 
such as sterol esters or triacylglycerols. 
Numerous proteins, many of which play 
functional roles in LD biology, decorate 
their surfaces. LDs are therefore struc-
turally similar to plasma lipoproteins, 
which are secreted from cells and trans-
port lipids through the aqueous circula-
tion to different regions of the body.
We are just beginning to understand 
fundamental aspects of LD biogenesis, 
catabolism, and functional activities in 
cells. This increased knowledge of LD 
cell biology has relevance for applied 
science in the fields of human health and 
biofuels.
R—Recognition of Lipid Droplets as 
an Organelle
The earliest descriptions of lipid droplets 
date to the 19th century. Both Richard 
Altmann and E.B. Wilson described fat 
droplets in cells and speculated about 
their origin (Altmann, 1890; Wilson, 1896). 
Early on, the high diffraction properties 
of LDs facilitated their identification by 
light microscopy. With their recognition 
as a component of most cells in the early 
1900s came a respectable name for this organelle: the liposome. However, in 
the late 1960s, artificial liposomes were 
invented and quickly usurped the name. 
Since then, the organelles were called 
by many names, including lipid droplets, 
lipid bodies, fat bodies, fat droplets, and 
adiposomes. In plants, they are often 
called oil bodies. As the field rapidly 
evolves, it seems to be settling on the 
name “lipid droplets.”
Other than morphological stud-
ies, LDs received scant attention for 
decades. In 1991, the discovery of per-
ilipin, a phosphoprotein associated with 
LDs in adipocytes, brought new atten-
tion to the organelle (Greenberg et al., 
1991). Since then, the number of papers 
about LDs has increased dramatically. 
This may reflect numerous factors, 
including basic research related to obe-
sity and oil production, fields in which 
LD biology plays a prominent role, and 
the recognition of a virtually untapped 
frontier of cell biology.
E—Emerging Recognition of 
 Functional Roles in Cells
For many cells and organisms, energy 
supplies in the environment fluctuate 
between surplus and starvation, and 
the ability to store energy may provide a 
competitive evolutionary advantage. Cel-
lular energy is stored mainly in the form of 
triacylglycerols, which are hydrophobic, 
highly reduced, and concentrated mol-
ecules for storing energy. Within cells, 
energy storage is compartmentalized in 
LDs. Indeed, the most highly special-
ized cells dedicated to this process are 
adipocytes, in which LDs often occupy Cell 139, Nthe bulk of the cytoplasm. In mammals, 
energy storage and catabolism in LDs 
are highly regulated by hormones and 
signaling pathways.
LDs are also a repository for the build-
ing blocks for biological membranes, 
such as phospholipids and sterols. 
When needed, these lipids can be gen-
erated from catabolism and mobilization 
of lipids in LDs. In yeast, such hydrolysis 
of triacylglycerols has been linked to the 
cell cycle and is coupled with rapid mem-
brane expansion (Kurat et al., 2009).
By compartmentalizing lipids, LDs 
buffer cells from the toxic effects of 
excessive amounts of lipid. For example, 
macrophages can take up large amounts 
of cholesterol, which can trigger endo-
plasmic reticulum (ER) stress and even-
tually cell death by apoptosis or necrosis 
(Maxfield and Tabas, 2005). However, 
excess sterols can be detoxified by con-
version to sterol esters and storage in 
LDs, thereby protecting the cells against 
toxicity. Similar buffering through esteri-
fication and partitioning into LDs may 
protect cells from other lipids or lipo-
philic substances that may be toxic in 
excess (e.g., fatty acids or retinol).
LDs are involved in intracellular protein 
metabolism. For example, during devel-
opment of the fruit fly Drosophila, his-
tones accumulate at the surfaces of LDs 
until they are incorporated into rapidly 
dividing nuclei (Cermelli et al., 2006). The 
core protein of the hepatitis C virus also 
localizes to LDs during viral replication 
in hepatocytes (Miyanari et al., 2007). 
LDs also have been linked functionally to 
the spliceosome and proteasome (Cho ovember 25, 2009 ©2009 Elsevier Inc. 855
et al., 2007; Guo et al., 2008; 
Ohsaki et al., 2006). In the 
proteasome, LDs might serve 
as platforms for the deposi-
tion and degradation of some 
proteins.
S—Synthesis of Lipids for 
Growing Lipid Droplets
The growth of an LD requires 
the addition of both polar lip-
ids at the droplet surface and 
neutral lipids within the hydro-
phobic core. The polar lipids 
include primarily phospholip-
ids and sterols. Phospholip-
ids may be derived from de 
novo synthesis or by conver-
sion of glycerolipids, such as 
diacylglycerol derived from 
triacylglycerol hydrolysis. 
Although data are limited, the 
major phospholipids in LDs 
are phosphatidylcholine and 
phosphatidylethanolamine. 
The biosynthesis of these two 
phospholipids occurs pri-
marily in the ER. It is unclear 
how a need for synthesis 
of phosphatidylcholine and 
phosphatidylethanolamine is 
sensed by a growing LD and 
how these phospholipids are 
added to the LD surface. In 
cells with limited phosphati-
dylcholine synthesis due to 
loss of CTP:phosphocholine 
cytidylyltransferase (the rate-
limiting enzyme), LDs are 
larger than normal, possibly 
in part because there is lim-
ited phosphatidylcholine for 
LD surfaces thus promoting 
the fusion of LDs (Guo et al., 
2008).
The growth of an LD can 
involve the addition of large 
amounts of triacylglycerols to its core, 
implying that triacylglycerol synthesis 
must be coordinated with LD growth. 
The synthesis of triacylglycerol in 
cells occurs mostly from the glycerol-
phosphate pathway in which fatty acid 
moieties are added sequentially to a 
glycerol backbone. In the final step of 
triacylglycerol synthesis, diacylglycerol 
and fatty acyl CoAs are converted to 
triacylglycerol in a reaction catalyzed by 
acyl CoA:diacylglycerol acyltransferases 
(DGAT) (Yen et al., 2008). Many of the 
enzymes in the triacylglycerol synthetic 
pathway, including DGAT enzymes, are 
found in the ER and mitochondria or in 
mitochondria-associated membranes 
and occur in multiple isoforms (Coleman 
and Lee, 2004; Yen et al., 2008).
How newly synthesized triacylglycerol 
is delivered to the cores of nascent LDs 
is unclear. The prevailing model posits 
that triacylglycerol is syn-
thesized within the ER and 
released between the leaf-
lets of the bilayer membrane. 
When triacylglycerol accu-
mulates over a certain thresh-
old, a fat lens is believed to 
form in the bilayer and bulge 
into the cytoplasm through 
a budding process. How the 
triacylglycerol is channeled to 
budding domains, how bud-
ding occurs mechanistically, 
and how the directionality of 
the budding is achieved are 
not understood. Indeed, little 
experimental evidence sup-
ports the budding model, 
and alternative models have 
been proposed (reviewed in 
Walther and Farese, 2009). For 
example, a speculative model 
that we proposed is “vesicu-
lar budding,” in which newly 
formed lipids might fill the 
bilayer of existing membrane 
vesicles, effectively filling 
the vesicle with neutral lipids 
(Walther and Farese, 2009). In 
a variation of this model, the 
ER bilayer is filled with neutral 
lipids and the resulting bulge 
does not detach from the ER. 
In this scenario, LDs would 
constitute a specialized ER 
domain that remains con-
nected to the ER bilayer. This 
would allow rapid exchange 
of lipids between the ER and 
LDs during synthesis and 
mobilization. However, when 
LDs grow, the high curvature 
of the membrane at the neck, 
formally resembling a hemifu-
sion intermediate, would likely 
require stabilizing proteins.
The addition of triacylglyc-
erol to the cores of LDs may also occur 
through the local synthesis of triacylg-
lycerol at the surfaces of LDs or in ER 
membranes adjacent to droplets. Two 
recent studies demonstrated triacylg-
lycerol synthesis in isolated droplets and 
linked this to the presence of enzymes 
(e.g., acyl-coenzyme A synthetase and 
DGAT2) that activate and esterify fatty 
acids (Fujimoto et al., 2007; Kuerschner 
et al., 2008).
Figure 1. Anatomy of a Lipid Droplet
(Top) An electron micrograph of a lipid droplet in a cultured hepatoma cell. 
The membrane monolayer surrounding the lipid droplet is visible, as are close 
associations with mitochondria and ER membranes. (Bottom) The structural 
features of a lipid droplet. Shown are polar surface lipids of the monolayer 
(e.g., phospholipids and sterols), the nonpolar lipids of the core (e.g., sterol 
esters and triacylglycerols), and a variety of proteins decorating the surface 
of the droplet. These proteins include DGAT2, Rab18, perilipin, and CCT 
(CTP:phosphocholine cytidylyltransferase; the rate-limiting enzyme in phos-
phatidylcholine synthesis). Several hypothetical mechanisms for how proteins 
interact with the lipid droplet are shown, including amphipathic α helices, 
embedding of hydrophobic regions directly in the droplet, and lipid anchors. 
(Electron micrograph courtesy of S. Stone and J. Wong; image reprinted from 
Biochim. Biophys. Acta 1791, T.C. Walter and R.V. Farese, Jr. (2009), with 
permission from Elsevier.)856 Cell 139, November 25, 2009 ©2009 Elsevier Inc.
Many LDs also contain large amounts 
of sterol esters. For example, sterol esters 
constitute about half of the neutral lipids 
in yeast LDs. In mammalian cells, sterol 
esters are the major neutral lipid in LDs 
of adrenocortical cells and macrophage 
foam cells in atherosclerotic lesions. Ste-
rol esters are synthesized from sterols 
and fatty acyl CoA in reactions catalyzed 
by sterol-O-acyltransferases. These 
enzymes, like DGATs, are localized in the 
ER, and it is unclear how their products 
are channeled to LD cores.
LDs might also “grow” through fusion 
of smaller LDs into larger LDs, but this is 
likely to be a rare event in most cell types. 
Although a few studies show appar-
ent fusion of LDs in time-lapse images 
(Boström et al., 2007; Guo et al., 2008), 
conclusive data for this mechanism are 
lacking. If fusion does occur, one possi-
ble mechanism is through simple phase 
coalescence. In fact, we speculate that 
specific proteins coating LD surfaces 
may prevent them from coalescing. This 
conjecture is supported by data in seeds 
of the model plant Arabidopsis thaliana 
in which deficiency of oleosin, the major 
structural LD protein, leads to apparent 
fusion of LDs (Siloto et al., 2006). Another 
possibility is that SNARE proteins medi-
ate LD fusion (Boström et al., 2007), simi-
lar to their roles in the fusion of vesicle 
bilayers, although evidence supporting 
this conjecture is limited.
P—Protein Targeting to Lipid 
Droplets
The metabolic functions of LDs may be 
partially mediated by proteins bound to 
their surface. How proteins are specifi-
cally targeted to LDs is unknown. Molec-
ular “zip codes,” such as sequences that 
direct proteins to the ER or mitochondria, 
have not been identified for LDs. Several 
distinct mechanisms might mediate tar-
geting of proteins to LDs.
Similar to the binding of some apo-
lipoproteins to lipoproteins, the bind-
ing of some proteins to LD surfaces 
involves amphipathic α helices. Perhaps 
the best studied example is Tip47, one 
of the family of LD-binding PAT proteins 
(perilipin, ADRP/adipophilin, Tip47, and 
related proteins). The crystal structure 
of a fragment of Tip47 revealed struc-
tural similarity to apolipoprotein (apo) E 
(Hickenbottom et al., 2004), with a four-helix bundle that contains amphipathic 
α helices. By analogy to apoE’s binding 
to lipoproteins, the four-helix bundle of 
Tip47 may open to facilitate the binding 
of the internal hydrophobic helices to 
the surface of LDs. Binding via amphip-
athic α helices is a likely mechanism for 
other proteins that are targeted to LD 
surfaces. How such proteins would dis-
tinguish between the LD surface mono-
layer and the bilayer of other organelle 
surfaces is unknown. One possibility is 
that LD specificity might be achieved by 
a dynamic interplay between specific 
surface lipids and the proteins that bind 
and modify them.
Proteins might also target LDs through 
a hydrophobic domain that embeds in 
the LD surface. This domain could be 
at the N or C terminus or lie within an 
internal region of a protein, which would 
result in surrounding hydrophilic regions 
of the protein projecting from the droplet 
surface. Examples of the latter include 
DGAT2, hepatitis C virus core protein, 
and caveolins (Boulant et al., 2006; 
Martin and Parton, 2006; Ostermeyer 
et al., 2004; Thiele and Spandl, 2008). 
Such a topology would enable proteins 
to move from a bilayer membrane to a 
monolayer LD surface. For example, 
caveolin is normally located in specific 
plasma membrane domains via a long 
hydrophobic stretch that is embedded 
in the membrane bilayer. When cells are 
incubated with fatty acids, a significant 
fraction of caveolin localizes to LDs 
(Robenek et al., 2004). A similar mecha-
nism involving the ER bilayer and LDs 
has been suggested for DGAT2 (Stone 
et al., 2009; Thiele and Spandl, 2008). 
The targeting of proteins to LDs through 
lipid modifications, similar to mecha-
nisms that target proteins to membrane 
bilayers, also seems likely, although 
there is no direct evidence as yet for this 
mechanism.
How such proteins would dynami-
cally change their localization from a 
bilayer membrane to an LD monolayer 
is unclear. It seems unlikely that a long 
lipid-embedded domain is extracted 
from membranes during relocalization. If 
LDs remain contiguous with membranes, 
such as the ER, the protein might directly 
diffuse from the bilayer to the LD. Alter-
natively, membrane vesicular traffic may 
connect the plasma membrane or ER Cell 139, Nwith LDs. Two lines of evidence sup-
port this possibility. First, biochemical 
approaches reconstituting in vitro ves-
icle formation from yeast microsomes 
have led to identification of a vesicle 
population that might connect the ER 
with LDs (Takeda and Nakano, 2008). 
Second, two independent RNAi screens 
identified a crucial function for the Arf1/
COPI vesicular transport machinery in 
LD morphology and lipolysis (Beller et 
al., 2008; Guo et al., 2008). A defect in 
lipolysis in cells lacking Arf1/COPI com-
ponents may be due at least partially to 
a requirement for trafficking of the adi-
pose triglyceride lipase (ATGL), the major 
triglyceride lipase, to LDs (Beller et al., 
2008; Soni et al., 2009). Given that Arf1/
COPI proteins have a canonical function 
in vesicle generation in the Golgi appara-
tus, they might also function in vesicular 
trafficking to LDs. This model, however, 
presents a topological problem. How 
would vesicles surrounded by a bilayer 
membrane fuse with the monolayer sur-
rounding the LDs? A membrane hemi-
fusion of the outer vesicle bilayer with 
the surface monolayer of an LD would 
provide one solution for the transfer of 
lipids or proteins, but this idea is highly 
speculative.
Complicating the interpretation of most 
protein localization data is that some 
proteins observed in LDs may actually 
be localized to membranes close to the 
LDs. Many electron micrographs show 
ER membranes immediately adjacent 
to the LD surface, and light microscopy 
methods lack sufficient resolution to 
distinguish the exact localization of pro-
teins between the LD surface and adja-
cent membranes. For example, DGAT2, 
an ER enzyme, localizes to LDs when 
cells are treated with fatty acids, but it 
is unclear if this reflects targeting to the 
LD surface or to an adjacent ER bilayer 
compartment (Kuerschner et al., 2008; 
Stone et al., 2009). Similarly, ADRP/adi-
pophilin, which is considered a “classic” 
LD surface protein by light microscopy 
studies, has a significant pool in the LD-
juxtaposed ER membrane (Robenek et 
al., 2006). Proteins that lack transmem-
brane domains but have hydrophobic 
domains could exchange between the 
two compartments, either by diffusion if 
the membranes were contiguous or by a 
shuttling mechanism.ovember 25, 2009 ©2009 Elsevier Inc. 857
E—Endoplasmic Reticulum: The Site 
of LD Biogenesis?
Although formal proof is lacking, the cur-
rent model for LD biogenesis posits that 
the organelles are derived from the ER. 
This is logical inasmuch as the enzymes 
(e.g., DGAT and ACAT) that synthesize 
neutral lipids for the cores of LDs are 
localized primarily in the ER, and ER 
membranes are often found close to LDs 
(for examples, see Blanchette-Mackie et 
al., 1995). Additionally, a recent freeze-
fracture study revealed that a large por-
tion of LDs are surrounded by ER mem-
branes, similar to an egg cup holding 
an egg (Robenek et al., 2006). In yeast, 
nascent LDs are almost universally found 
in close proximity with ER membranes 
(N. Krahmer, P. Mardones, and T.C.W., 
unpublished data; Goodman, 2008).
Contact sites between LDs and the ER 
could serve several functions. One can 
envision a model in which LDs bulging 
from the ER maintain a physical connec-
tion with the ER, which could be stabilized 
by a specialized set of proteins. Such a 
connection could facilitate the exchange 
of proteins or lipids between the com-
partments. During lipolysis, for example, 
the diacylglycerols and fatty acids gener-
ated could be directly transferred to the 
ER for phospholipid synthesis. Similarly, a 
sterol transfer protein that was identified 
on the surface of LDs could mediate the 
transport of released sterol back to the 
ER (Hynynen et al., 2009).
Additionally, LDs may associate func-
tionally with other organelles. For exam-
ple, in bacteria, which lack an ER, evi-
dence suggests that LDs originate from 
the plasma membrane (Wältermann et al., 
2005). Other studies have shown that LDs 
interact with membranes of peroxisomes, 
mitochondria, or replication vacuoles of 
intracellular parasites (reviewed in Good-
man, 2008; Walther and Farese, 2009).
Few proteins have been identified as 
crucial for LD formation. Genomewide 
screens in Drosophila cells identified 
many genes whose loss of function 
results in fewer or smaller lipid droplets 
(Beller et al., 2008; Guo et al., 2008). 
Similar screens in yeast suggest that 
seipin (encoded by the FLD1 gene) is 
involved (Fei et al., 2008; Szymanski et 
al., 2007), but mechanistic insights are 
lacking. Tip47 also has been implicated 
in LD biogenesis (Bulankina et al., 2009).858 Cell 139, November 25, 2009 ©2009 ElC—Catabolism of Lipid Droplets
When cells need lipids to generate 
energy or synthesize membranes, 
lipolysis is activated to mobilize these 
substrates. During lipolysis of triacyl-
glycerols, individual fatty acyl chains 
are sequentially cleaved from the glyc-
erol backbone. In mammalian adipose 
tissue, lipolysis is highly regulated 
and induced by catecholamines dur-
ing fasting or exercise (Zechner et al., 
2009). Catecholamines bind to G pro-
tein-coupled receptors, leading to an 
increase in intracellular cAMP via acti-
vation of adenylate cyclase and, as a 
consequence, the activation of protein 
kinase A (PKA). In turn, PKA phospho-
rylates a number of proteins, including 
hormone-sensitive lipase and perilipin 
(Brasaemle et al., 2009). Phosphory-
lation of perilipin triggers release of 
CGI-58, a coactivator of ATGL. Subse-
quently, ATGL is recruited to LDs, where 
the complex catalyzes the removal of 
the first acyl chain from triacylglycerols. 
Phosphorylation of hormone-sensitive 
lipase activates this enzyme, leading to 
relocalization to the LD surface, where 
it cleaves the second acyl chain, to 
yield monoacylglycerol. The last acyl 
chain is removed by monoacylglycerol 
lipase, and glycerol is released. Dur-
ing this process, the different lipases 
are targeted directly to the surface of 
the LD to interact with their respective 
substrates. But how, for example, ATGL 
penetrates the LD-delimiting monolayer 
and accesses triacylglycerols located in 
the core is unknown. We speculate that 
a lipase, or a protein complex involving 
a lipase, binds to the LD surface and 
effectively parts the surface phospho-
lipid monolayer, allowing a neutral lipid 
in the core to access the catalytic site 
of an overlying lipase. Some evidence 
from cultured cells suggests that, under 
maximum stimulation of lipolysis, LDs 
may break up into smaller LDs, which 
would provide more surface area for 
lipases. Whether this occurs in normal 
physiology is unknown. Such a process 
could be facilitated by proteins that 
deform membranes and initiate bud-
ding, such as coatamer proteins (Guo et 
al., 2008). LDs may also get degraded 
by autophagy (Singh et al., 2009), but 
the relative contribution of this pathway 
to lipolysis is not clear. Autophagy could sevier Inc.provide a mechanism for bulk recycling 
of lipids for cellular utilization, in con-
trast to the more selective, and hormon-
ally induced, lipolytic mechanisms that 
provide release of lipids from cells.
T—Translational Relevance and 
Tomorrow’s Research
LDs play an important role in diseases 
of excess triacylglycerol storage, such 
as obesity and metabolic syndrome, 
which often lead to cardiovascular com-
plications and the development of type 2 
diabetes. Indeed, many diseases, such 
as obesity, diabetes, and fatty liver dis-
ease, could be referred to as “diseases of 
excessive LDs.” LDs in adipocytes, mus-
cle cells, hepatocytes, and cardiac myo-
cytes likely protect cells from the effects 
of too much fat. Yet, in many instances, 
excessive lipid deposition may exceed the 
capacity of cells and lead to dysfunction, 
termed lipotoxicity (reviewed in Schaffer, 
2003). This raises the interesting and so 
far unanswered question of what deter-
mines the capacity of a cell to store fat. 
Several studies have shown that increas-
ing the capacity for triacylglycerol synthe-
sis in cells or tissues is protective in some 
instances (Yen et al., 2008). Interestingly, 
the protein Fsp27/CIDEC regulates fat 
storage in adipocytes (Gong et al., 2009) 
and might also regulate the storage 
capacity of LDs (Keller et al., 2008). Also, 
rare genetic disorders result in excessive 
LDs in tissues: homozygous deficiency 
of ATGL or CGI-58 causes neutral lipid 
storage disease and is associated with 
myopathy or skin ichthyosis, respectively 
(Schweiger et al., 2009).
LDs also play a major role in athero-
sclerosis. In atherosclerotic arteries, 
cholesterol esters accumulate in LDs of 
macrophages resulting in “foam cells,” 
which are hallmarks of atherosclerotic 
lesions. In foam cells, LDs likely serve 
to buffer the cells against toxicity from 
excessive amounts of unesterified ste-
rols. If macrophages are overwhelmed 
by excessive amounts of lipids, they 
may undergo apoptotic and necrotic cell 
death, contributing to lesion instabil-
ity and, ultimately, to stroke and heart 
attack (Maxfield and Tabas, 2005). 
Besides metabolic diseases, LDs func-
tion in the intracellular replication of sev-
eral infectious agents, including Chla-
mydia and hepatitis C virus (Boulant et 
al., 2007; Cocchiaro et al., 2008; Ogawa 
et al., 2009), suggesting new therapeutic 
angles for these infections.
Apart from diseases, LDs are engen-
dering intense study in the applied sci-
ence of oil production for nutrition or 
biofuel purposes. Generating animals 
or crops with altered or maximized lipid 
production has long occurred through 
breeding and will likely increase with 
genetic engineering. Additionally, efforts 
to industrially produce LDs in algae or 
bacteria as sources of biofuels to provide 
energy are rapidly increasing (Service, 
2009). Traditionally, plant oils, stored in 
lipid bodies (the functional equivalents of 
LDs in plants), were produced in species 
such as Brassica napus and processed 
to yield biodiesel. The current engineer-
ing of photosynthetic microorganisms 
such as algae promises to bring indus-
trial scale production of oil to a new 
arena.
Conclusion
We have touched on most of the fun-
damental questions concerning LDs 
that remain unanswered, such as those 
pertaining to their functions, formation, 
growth, and catabolism. One additional 
question is whether all organelles now 
called LDs are indeed equivalent or merely 
resemble each other. For example, are 
the sterol-rich droplets in macrophage 
foam cells similar in protein composition 
to lipid droplets in triacylglycerol-rich 
adipocytes? Might different types of LDs 
originate through different mechanisms? 
At least for LDs formed in bacteria, it is 
already clear that the mechanisms differ 
from those in eukaryotes.
These questions provide a wealth of 
research opportunities, from biophys-
ics to cell biology to lipid and energy 
metabolism in multicellular organisms. 
Some challenges that must be solved are 
methodological, and advances in these 
areas would greatly serve the field. For 
example, the application of high-resolu-
tion techniques of light microscopy might 
provide insights into the relationship of 
LDs with other organelles, such as the 
ER. Biochemical techniques to purify 
subpopulations of LDs, analogous to 
techniques to separate classes of plasma 
lipoproteins, might be extremely valuable. 
The development of methods to generate 
artificial LDs, similar to bilayer liposomes, would enable detailed biochemical and 
biophysical studies of phenomena such 
as LD fusion or protein targeting.
The field of LD biology is on the cusp 
of a new era of information. LDs are 
emerging from relative obscurity to rec-
ognition as dynamic structures with a 
complex and interesting biology that is 
highly integrated with other aspects of 
cell biology. Insights into the molecular 
aspects of LD biology will provide new 
information about physiology and dis-
ease and will provide fresh leads for the 
applied sciences. LDs are finally garner-
ing the respect they richly deserve.
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